Back to search results

Clinical Nurse Specialist-Led Early Palliative Survivorship Care for Advanced Cancer

This study is testing a new approach to care for adults (21 years and older) with advanced solid tumors (cancers that start in organs like the breast or lung and have spread). It compares a program led by an oncology clinical nurse specialist, which focuses on early palliative (comfort) and survivorship care, against the usual care you would receive. The main goal is to see if this new approach can reduce your symptoms over 24 months. Researchers also want to see if it improves your quality of life, reduces distress, and affects overall survival. You might be eligible if you have a metastatic solid tumor with a favorable or very favorable prognosis and are receiving care at GSUH oncology or radiation oncology.

Study design
This is a randomized study, meaning participants are assigned by chance to either the new care model or standard care. About 100 participants will be enrolled.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for symptom burden for 24 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05947695

Clinical Nurse Specialist Led Early Palliative Survivorship Care for Patients With Advanced Cancer

Recruiting
NAAges 21+InterventionalSupportive care
Good Samaritan Hospital Medical Center, New York
~100 participants
Updated 2023-09-13 on ClinicalTrials.gov
What's tested:Palliative and Survivorship Care Model

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
participant reported symptom burden
Measured over 24 months

Conditions

Solid Tumor, Adult
Metastasis

Explore related trials

Solid Neoplasm

NCT05947695

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Good Samaritan University Hospital

    West Islip, New Yorkstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Johnny Kao, MD · STUDY_CHAIR · Good Samaritan University Hospital

Who to contact

Johnny Kao, MD
[email protected]
631-376-4047
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

adult patients (21 yrs and over)
metastatic solid tumor malignancy with very favorable and favorable prognostic curves
under the care of GSUH oncology and radiation oncology clinicians

Exclusion

patients with metastatic solid tumor malignancy who are \< 21 yrs of age
adult patients with metastatic solid tumor malignancy who are in standard risk and unfavorable prognostic curves
patients not under the care of GSUH oncology and radiation oncology clinicians

What this trial measures

  • participant reported symptom burden24 months

    The Edmonton Symptom Assessment System- Revised (ESAS-r) will be used to measure patient reported symptom burden